- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0028905

Heal Remedics Private Limited
About Heal Remedics Private Limited
Data last updated:
Heal Remedics Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2010PTC039305. Its GSTIN is 09AACCH3277P1ZZ (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lokesh Anand and Divya Anand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 74 Vibhuti Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.7 Cr, a growth of 118% compared to the previous year. For the same year it recorded a net profit of ₹8.35 Lakh (net margin 1.8%) and EBITDA of ₹15.73 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 44% over five years.
As per MCA filings, the company has open charges of ₹29.75 Lakh and satisfied charges of ₹29.75 Lakh on record.
Heal Remedics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0028905). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Heal Remedics
Contact details
Heal Remedics Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 74 Vibhuti Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Heal Remedics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Heal Remedics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Heal Remedics Private Limited, buy the company report.
Financials of Heal Remedics Private Limited
FY 2025 filings availableHeal Remedics Private Limited reported revenue of ₹4.7 Cr (up 118% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 118% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Heal Remedics Private Limited, buy the company report.
Board of directors of Heal Remedics Private Limited
Heal Remedics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Anand Also directs: Aj Food & Beverages LLP, Biolek Pharmaceuticals LLP | Director | 20 Jan 2010 | 16 Years 9 Months | Current |
| Divya Anand Also directs: Aj Food & Beverages LLP, Biolek Pharmaceuticals LLP | Director | 20 Jan 2010 | 16 Years 9 Months | Current |
Peer comparison
Heal Remedics Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jack Smith India Private Limited | ₹4.74 Cr (FY 2025) | 149.0% | Gmc, Assam, India | |||
| Rudralife Science Private Limited | ₹4.72 Cr (FY 2024) | 13.0% | Selaqui, Uttarakhand, India | |||
| Heal Remedics Private Limitedthis company | ₹4.7 Cr (FY 2024) | ₹8.35 Lakh | 1.8% | 118.0% | Lucknow, Uttar Pradesh, India | |
| Charan Laboratories Private Limited | ₹4.68 Cr (FY 2025) | -5.0% | New Delhi, Delhi, India |
To see the full peer comparison of Heal Remedics Private Limited, buy the company report.
Auditor
Heal Remedics Private Limited is audited by GARG VERMA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG VERMA & ASSOCIATES | FY 2020 | 016510C |
Shareholding
The shareholding of Heal Remedics Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Heal Remedics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Oct 2010 | 10249498 | Indian Overseas Bank | ₹29.75 Lakh | Satisfied |
To see the full charge records of Heal Remedics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Heal Remedics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Heal Remedics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Heal Remedics has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCH3277P1ZZ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Heal Remedics Private Limited, buy the company report.
Recent activity
Heal Remedics Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Girish Anand ceased to be Director on 05 Dec 2023.
Frequently asked questions
Heal Remedics is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 January 2010 (16+ years old) and is registered under CIN U24233UP2010PTC039305.
Heal Remedics has 2 current directors:
- Lokesh Anand - Director
- Divya Anand - Director
The latest financial statements of Heal Remedics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Heal Remedics is 09AACCH3277P1ZZ, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Heal Remedics is U24233UP2010PTC039305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heal Remedics was incorporated on 20 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Heal Remedics by revenue are Jack Smith India Private Limited, Rudralife Science Private Limited, Charan Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Girish Anand ceased to be Director on 05 Dec 2023. Divya Anand was appointed as Director on 20 Jan 2010. Lokesh Anand was appointed as Director on 20 Jan 2010.
Yes, Heal Remedics is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0028905).
The registered office of Heal Remedics is at D – 74 Vibhuti Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Heal Remedics operates in the pharma industry, in the drug formulation and development segment.

